Immunity:Foxp3驱动的表观遗传修饰失控的危害

2012-05-19 刘纯 生物谷

调节性T细胞(Treg)在限制自身免疫和慢性炎症中发挥着重要作用, 而调节性T细胞的生成由转录因子Foxp3调控。 5月10日,国际著名期刊Immunity 在线发表了圣犹大儿童研究医院等机构的一篇题为Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cel

调节性T细胞(Treg)在限制自身免疫和慢性炎症中发挥着重要作用, 而调节性T细胞的生成由转录因子Foxp3调控。

5月10日,国际著名期刊Immunity 在线发表了圣犹大儿童研究医院等机构的一篇题为Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency的研究论文,研究发现Foxp3驱动的表观遗传修饰失控将导致调节性T细胞的不足,进而使得机体在易感环境下发生自身免疫。

Foxp3gfp 是一个亚等位基因。研究发现,它在NOD背景的小鼠中大大加速自身免疫糖尿病的发生。虽然在NOD和C57B L/6背景的小鼠中,天然调节性T细胞的生长和功能在体外没有显著地改变,但是在炎症环境下天然调节性T细胞功能被扰乱,并且TGF-β介导的调节性T细胞的生长也在减缓。Foxp3gfp不能与组氨酸乙酰转移酶Tip60、组氨酸脱乙酰酶HDAC7和Ikaros家族锌指4(Eos)等发生相互作用,这将减少Foxp3的乙酰化,并提高K48J连接的多聚泛素化。这些将导致Foxp3驱动的转录谱改变和Foxp3介导的基因表达水平的降低。

这表明,Foxp3驱动的表观遗传修饰失控将导致调节性T细胞的不足,进而使得机体在易感环境下会发生自身免疫。(生物谷Bioon.com)

doi.org/10.1016/j.immuni.2012.03.020

PMC:
PMID:

Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency

Matthew L.Bettini,Fan Pan,Maria Bettini,David Finkelstein,Jerold E.Rehg,Stefan Floess,Bryan D.Bell,Steven F.Ziegler,Jochen Huehn,Drew M.Pardoll,Dario A.A.Vignali

1 Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105,USA

2 Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA

3 Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105,USA

4 Immunology and Hematopoiesis Division, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA

5 Experimental Immunology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig,Germany

6 Benaroya Research Institute, Seattle, WA 98101, USA

Summary

Regulatory T (Treg) cells,driven by the Foxp3 transcription factor,are responsible for limiting autoimmunity and chronic inflammation. We showed that a well-characterized Foxp3gfp reporter mouse,which expresses an N-terminal GFP-Foxp3 fusion protein,is a hypomorph that causes profoundly accelerated autoimmune diabetes on a NOD background. Although natural Treg cell development and in vitro function are not markedly altered in Foxp3gfp NOD and C57BL/6 mice,Treg cell function in inflammatory environments was perturbed and TGF-β-induced Treg cell development was reduced. Foxp3gfp was unable to interact with the histone acetyltransferase Tip60,the histone deacetylase HDAC7,and the Ikaros family zinc finger 4, Eos,which led to reduced Foxp3 acetylation and enhanced K48-linked polyubiquitylation. Collectively this results in an altered transcriptional landscape and reduced Foxp3-mediated gene repression,notably at the hallmark IL-2 promoter. Loss of controlled Foxp3-driven epigenetic modification leads to Treg cell insufficiency that enables autoimmunity in susceptible environments.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1653778, encodeId=696e1653e78b9, content=<a href='/topic/show?id=8d02e630a6' target=_blank style='color:#2F92EE;'>#FOXP3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7630, encryptionId=8d02e630a6, topicName=FOXP3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be7924361871, createdName=zhs3890, createdTime=Sat Apr 06 10:15:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030262, encodeId=7525203026284, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Aug 07 10:15:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075637, encodeId=6cfb20e56378f, content=<a href='/topic/show?id=afce902528d' target=_blank style='color:#2F92EE;'>#表观遗传修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90252, encryptionId=afce902528d, topicName=表观遗传修饰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Tue Oct 30 04:15:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569249, encodeId=b1bd156924966, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2013-04-06 zhs3890
  2. [GetPortalCommentsPageByObjectIdResponse(id=1653778, encodeId=696e1653e78b9, content=<a href='/topic/show?id=8d02e630a6' target=_blank style='color:#2F92EE;'>#FOXP3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7630, encryptionId=8d02e630a6, topicName=FOXP3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be7924361871, createdName=zhs3890, createdTime=Sat Apr 06 10:15:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030262, encodeId=7525203026284, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Aug 07 10:15:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075637, encodeId=6cfb20e56378f, content=<a href='/topic/show?id=afce902528d' target=_blank style='color:#2F92EE;'>#表观遗传修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90252, encryptionId=afce902528d, topicName=表观遗传修饰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Tue Oct 30 04:15:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569249, encodeId=b1bd156924966, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1653778, encodeId=696e1653e78b9, content=<a href='/topic/show?id=8d02e630a6' target=_blank style='color:#2F92EE;'>#FOXP3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7630, encryptionId=8d02e630a6, topicName=FOXP3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be7924361871, createdName=zhs3890, createdTime=Sat Apr 06 10:15:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030262, encodeId=7525203026284, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Aug 07 10:15:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075637, encodeId=6cfb20e56378f, content=<a href='/topic/show?id=afce902528d' target=_blank style='color:#2F92EE;'>#表观遗传修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90252, encryptionId=afce902528d, topicName=表观遗传修饰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Tue Oct 30 04:15:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569249, encodeId=b1bd156924966, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1653778, encodeId=696e1653e78b9, content=<a href='/topic/show?id=8d02e630a6' target=_blank style='color:#2F92EE;'>#FOXP3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7630, encryptionId=8d02e630a6, topicName=FOXP3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be7924361871, createdName=zhs3890, createdTime=Sat Apr 06 10:15:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030262, encodeId=7525203026284, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Aug 07 10:15:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075637, encodeId=6cfb20e56378f, content=<a href='/topic/show?id=afce902528d' target=_blank style='color:#2F92EE;'>#表观遗传修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90252, encryptionId=afce902528d, topicName=表观遗传修饰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Tue Oct 30 04:15:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569249, encodeId=b1bd156924966, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-05-21 zhangyxzsh

相关资讯

肿瘤细胞免疫治疗策略

     郭亚军教授           相关幻灯资料   肿瘤细胞免疫治疗是继手术、放疗、化疗三大传统手段后的新支柱性治疗手段,最大的优势在于个体性、安全性、靶向性和高效性。肿瘤细胞免疫疗法并不能完全代替传统的治疗方法,但是可以起到辅助治疗作用,在手术、放化疗后获释患者放化疗间歇期使用肿瘤细胞免疫疗法效果较为显著。4月13日,在全国第五

Anesthesiology:针刺预处理具有强大免疫调节作用

近日,国际著名杂志Anesthesiology刊登了来自上海交通大学医学院附属仁济医院的研究人员的研究成果“Electroacupuncture Improves Survival in Rats with Lethal Endotoxemia via the Autonomic Nervous System,”,文章中,研究者发现针刺预处理具有强大的免疫调节作用,可使内毒素血症大鼠的生存率由20

PLoS One:研究证实蜜蜂可对抗真菌 自我医疗

美国北卡罗莱纳州立大学的一项研究显示,当蜂群感染上有害的真菌时,蜜蜂会“自我治疗”,采集更多数量的抗真菌植物树脂,以抵挡真菌的侵袭。 相关论文3月29日在线发表于《公共科学图书馆.综合》(PLoS ONE),论文的主要作者北卡州立大学昆虫系的博士后研究员迈克尔 西蒙妮-芬斯特隆(Michael Simone-Finstrom)说,让工蜂耗费精力采集这些树脂,演化出这种行为应该是由于其利大于弊。

Nature:美科学家发现PPAR-γ 的重要作用

5月16日,Nature在线发表了哈佛医学院微生物与免疫学系等机构的一篇题为PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells 的研究论文,揭示了噻唑烷二酮药物作用疾病的细胞机制,并证明了具有独特功能的调节性T细胞的独立类群能精确地用于治疗疾病。 在过去的几十年来,肥胖和Ⅱ

Cancer Res:缓解免疫功能紊乱促进老年鼠肿瘤免疫疗效

老年人比年轻人更可能患癌症,老年人的身体往往往往不能不足以打肿瘤这一战,接受治疗产生的毒副作用也较多。 但圣安东尼奥得克萨斯大学健康科学中心大学癌症治疗和研究中心的研究表明:以前认为某些只有在年轻患者体内发挥作用的免疫类型也可以用来帮助老年肿瘤患者。 医药卫生科学中心公共卫生硕士Tyler Curiel医学博士、教授说:我们已经证明,免疫治疗不仅对老年癌症小鼠有效,实际上免疫治疗可能对老年癌症

JBC: NK细胞的激活需要络氨酸激酶Btk

Bruton酪氨酸激酶不仅对B细胞的发育及分化至关重要,也参与调节了Toll样受体(TLR)引起的巨噬细胞的先天性免疫反应。然而,Btk是否参与调节了NK细胞的先天性免疫功能目前还不明确。近日,来自第二军医大的研究人员阐明了该机制。 他们发现,在老鼠NK细胞的成熟及激活期间,Btk的表达表现上调。应答TLR3配体时,老鼠Btk-/- NK细胞的免疫反应下降,同时IFN-γ、穿孔素及颗粒酶B的表达